[Congressional Record Volume 168, Number 58 (Friday, April 1, 2022)]
[House]
[Pages H4111-H4115]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




      MOMENT OF SILENCE IN REMEMBRANCE OF OFFICER WILLIAM F. EVANS

  The SPEAKER pro tempore (Mr. Neal). The Chair asks all those present 
in the Chamber, as well as Members and staff throughout the Capitol, to 
please rise for a moment of silence in remembrance of Officer William 
F. Evans, son of Massachusetts, United States Capitol Police Officer, 
who was killed in the line of duty defending our Capitol on April 2, 
2021.


                  Amendment No. 2 Offered by Mr. Lamb

  The SPEAKER pro tempore. Pursuant to clause 8 of rule XX, the 
unfinished business is the question on amendment No. 2, printed in part 
B of House Report 117-285, on which further proceedings were postponed 
and on which the yeas and nays were ordered.
  The Clerk will redesignate the amendment.
  The Clerk redesignated the amendment.
  The SPEAKER pro tempore. The question is on the amendment offered by 
the gentleman from Pennsylvania (Mr. Lamb).
  This is a 5-minute vote.
  The vote was taken by electronic device, and there were--yeas 234, 
nays 189, not voting 6, as follows:

                             [Roll No. 104]

                               YEAS--234

     Adams
     Aguilar
     Allred
     Auchincloss
     Axne
     Barragan
     Bass
     Beatty
     Bera
     Beyer
     Bishop (GA)
     Blumenauer
     Blunt Rochester
     Bonamici
     Bourdeaux
     Bowman
     Boyle, Brendan F.
     Brown (MD)
     Brown (OH)
     Brownley
     Bush
     Butterfield
     Carbajal
     Cardenas
     Carson
     Carter (LA)
     Cartwright
     Case
     Casten
     Castor (FL)
     Castro (TX)
     Cherfilus-McCormick
     Chu
     Cicilline
     Clark (MA)
     Clarke (NY)
     Cleaver
     Clyburn
     Cohen
     Connolly
     Cooper
     Correa
     Costa
     Courtney
     Craig
     Crist
     Crow
     Cuellar
     Davids (KS)
     Davis, Danny K.
     Dean
     DeFazio
     DeGette
     DeLauro
     DelBene
     Delgado
     Demings
     DeSaulnier
     Deutch
     Dingell
     Doggett
     Doyle, Michael F.
     Escobar
     Eshoo
     Espaillat
     Evans
     Fitzpatrick
     Fletcher
     Foster
     Frankel, Lois
     Gallego
     Garamendi
     Garcia (IL)
     Garcia (TX)
     Golden
     Gomez
     Gonzalez, Vicente
     Gottheimer
     Green, Al (TX)
     Griffith
     Grijalva
     Grothman
     Harder (CA)
     Hayes
     Higgins (NY)
     Himes
     Hollingsworth
     Horsford
     Houlahan
     Hoyer
     Huffman
     Jackson Lee
     Jacobs (CA)
     Jayapal
     Jeffries
     Johnson (GA)
     Johnson (OH)
     Johnson (SD)
     Johnson (TX)
     Jones
     Joyce (OH)
     Kahele
     Kaptur
     Katko
     Keating
     Kelly (IL)
     Khanna
     Kildee
     Kilmer
     Kim (CA)
     Kim (NJ)
     Kind
     Kirkpatrick
     Krishnamoorthi
     Kuster
     Lamb
     Langevin
     Larsen (WA)
     Larson (CT)
     Lawrence
     Lawson (FL)
     Lee (CA)
     Lee (NV)
     Leger Fernandez
     Levin (CA)
     Levin (MI)
     Lieu
     Lofgren
     Lowenthal
     Luria
     Lynch
     Mace
     Malinowski
     Maloney, Carolyn B.
     Maloney, Sean
     Manning
     Matsui
     McBath
     McCollum
     McEachin
     McGovern
     McNerney
     Meeks
     Meijer
     Meng
     Mfume
     Moore (WI)
     Morelle
     Moulton
     Mrvan
     Murphy (FL)
     Nadler
     Napolitano
     Neal
     Neguse
     Newhouse
     Newman
     Norcross
     O'Halleran
     Obernolte
     Ocasio-Cortez
     Omar
     Palazzo
     Pallone
     Panetta
     Pappas
     Pascrell
     Payne
     Perlmutter
     Peters
     Phillips
     Pingree
     Porter
     Pressley
     Price (NC)
     Quigley
     Raskin
     Reed
     Rice (NY)
     Ross
     Roybal-Allard
     Ruiz
     Ruppersberger
     Rush
     Ryan
     Sanchez
     Sarbanes
     Scanlon
     Schakowsky
     Schiff
     Schneider
     Schrader
     Schrier
     Scott (VA)
     Scott, David
     Sewell
     Sherman
     Sherrill
     Sires
     Slotkin
     Smith (WA)
     Soto
     Spanberger
     Speier
     Stansbury
     Stanton
     Stevens
     Strickland
     Suozzi
     Swalwell
     Takano
     Thompson (CA)
     Thompson (MS)
     Titus
     Tlaib
     Tonko
     Torres (CA)
     Torres (NY)
     Trahan
     Trone
     Underwood
     Upton
     Vargas
     Veasey
     Velazquez
     Wasserman Schultz
     Waters
     Watson Coleman
     Welch
     Wexton
     Wild
     Williams (GA)
     Wilson (FL)
     Yarmuth

                               NAYS--189

     Aderholt
     Allen
     Amodei
     Armstrong
     Arrington
     Babin
     Bacon
     Baird
     Balderson
     Banks
     Barr
     Bentz
     Bergman
     Bice (OK)
     Biggs
     Bilirakis
     Bishop (NC)
     Boebert
     Bost
     Brady
     Brooks
     Buchanan
     Buck
     Bucshon
     Burchett
     Burgess
     Calvert
     Cammack
     Carey
     Carl
     Carter (GA)
     Carter (TX)
     Cawthorn
     Chabot
     Cline
     Cloud
     Clyde
     Cole
     Comer
     Crawford
     Crenshaw
     Curtis
     Davidson
     Davis, Rodney
     DesJarlais
     Diaz-Balart
     Donalds
     Duncan
     Dunn
     Ellzey
     Emmer
     Estes
     Fallon
     Feenstra
     Ferguson
     Fischbach
     Fitzgerald
     Fleischmann
     Foxx
     Franklin, C. Scott
     Fulcher
     Gaetz
     Gallagher
     Garbarino
     Garcia (CA)
     Gibbs
     Gimenez
     Gohmert
     Gonzales, Tony
     Good (VA)
     Gooden (TX)
     Gosar
     Granger
     Graves (LA)
     Graves (MO)
     Green (TN)
     Greene (GA)
     Guest
     Guthrie
     Harris
     Harshbarger
     Hartzler
     Hern
     Herrell
     Herrera Beutler
     Hice (GA)
     Higgins (LA)
     Hill
     Hinson
     Hudson
     Huizenga
     Issa
     Jackson
     Jacobs (NY)
     Jordan
     Joyce (PA)
     Keller
     Kelly (MS)
     Kelly (PA)
     Kustoff
     LaHood
     LaMalfa
     Lamborn
     Latta
     LaTurner
     Lesko
     Letlow
     Long
     Loudermilk
     Lucas
     Luetkemeyer
     Malliotakis
     Mann
     Massie
     Mast
     McCarthy
     McCaul
     McClain
     McClintock
     McHenry
     McKinley
     Meuser
     Miller (IL)
     Miller (WV)
     Miller-Meeks
     Moolenaar
     Mooney
     Moore (AL)
     Moore (UT)
     Mullin
     Murphy (NC)
     Nehls
     Norman
     Owens
     Palmer
     Pence
     Perry
     Pfluger
     Pocan
     Posey
     Reschenthaler
     Rice (SC)
     Rodgers (WA)
     Rogers (AL)
     Rogers (KY)
     Rose
     Rosendale
     Rouzer
     Roy
     Rutherford
     Salazar
     Scalise
     Schweikert
     Scott, Austin
     Sessions
     Simpson
     Smith (MO)
     Smith (NE)
     Smith (NJ)
     Smucker
     Spartz
     Stauber
     Steel
     Stefanik
     Steil
     Steube
     Stewart
     Taylor
     Tenney
     Thompson (PA)
     Tiffany
     Timmons
     Turner
     Valadao
     Van Drew
     Van Duyne
     Wagner
     Walberg
     Walorski
     Waltz
     Weber (TX)
     Webster (FL)
     Wenstrup
     Westerman
     Williams (TX)
     Wilson (SC)
     Wittman
     Womack
     Zeldin

                             NOT VOTING--6

     Budd
     Bustos
     Cheney
     Gonzalez (OH)
     Johnson (LA)
     Kinzinger

                              {time}  1148

  So the amendment was agreed to.
  The result of the vote was announced as above recorded.


    MEMBERS RECORDED PURSUANT TO HOUSE RESOLUTION 8, 117TH CONGRESS

     Armstrong
     (Reschenthaler)
     Baird (Walorski)
     Barragan (Correa)
     Bass (Blunt Rochester)
     Bilirakis (Fleischmann)
     Bowman (Evans)
     Brooks (Fleischmann)
     Brown (OH) (Beyer)
     Cawthorn (Gaetz)
     Clarke (NY) (Velazquez)
     Cooper (Correa)
     Comer (Fleischmann)
     Crist (Wasserman Schultz)
     Cuellar (Pappas)
     Curtis (Moore (UT))
     Davis, Danny K. (Gomez)
     DeGette (Blunt Rochester)
     Deutch (Rice (NY))
     Donalds (Cammack)
     Espaillat (Correa)
     Ferguson (Kustoff)
     Frankel, Lois (Wasserman Schultz)
     Garcia (IL) (Takano)
     Garcia (TX) (Gomez)
     Gimenez (Diaz-Balart)
     Green (TN) (Fleischmann)
     Harder (CA) (Gomez)
     Jayapal (Gomez)
     Johnson (TX) (Beyer)
     Joyce (OH) (Garbarino)
     Kahele (Takano)
     Katko (Garbarino)
     Kelly (IL) (Blunt Rochester)
     Kind (Beyer)
     Kirkpatrick (Pallone)
     Krishnamoorthi (Beyer)
     LaMalfa (Palazzo)
     Lawson (FL) (Wasserman Schultz)
     Long (Fleischmann)
     Luetkemeyer (Meuser)
     Mace (Timmons)
     Manning (Beyer)
     McClain (Fitzgerald)
     McEachin (Wexton)
     McHenry (Rouzer)
     Meng (Kuster)
     Newman (Beyer)
     Owens (Moore (UT))
     Panetta (Gomez)
     Price (NC) (Connolly)
     Rice (SC) (Meijer)
     Roybal-Allard (Wasserman Schultz)
     Ryan (Kaptur)
     Salazar (Steube)
     Sanchez (Gomez)
     Scott, David (Correa)
     Sessions (Babin)
     Sires (Pallone)
     Speier (Scanlon)
     Steel (Obernolte)
     Stewart (Moore (UT))
     Strickland (Takano)
     Suozzi (Beyer)
     Taylor (Carter (TX))
     Thompson (MS) (Evans)
     Trone (Beyer)
     Waltz (Mast)
     Wilson (FL) (Evans)
     Wilson (SC) (Timmons)


                 amendment no. 3 offered by mr. raskin

  The SPEAKER pro tempore (Ms. Lee of California). Pursuant to clause 8 
of rule XX, the unfinished business is the question on amendment No. 3, 
printed in part B of House Report 117-285, on which further proceedings 
were postponed and on which the yeas and nays were ordered.
  The Clerk will redesignate the amendment.
  The Clerk redesignated the amendment.
  The SPEAKER pro tempore. The question is on the amendment offered by 
the gentleman from Maryland (Mr. Raskin).
  The vote was taken by electronic device, and there were--yeas 209, 
nays 214, not voting 6, as follows:

                             [Roll No. 105]

                               YEAS--209

     Adams
     Aguilar
     Allred
     Auchincloss
     Axne
     Barragan
     Bass
     Beatty
     Bera
     Beyer
     Bishop (GA)
     Blumenauer
     Blunt Rochester
     Bonamici
     Bourdeaux
     Bowman
     Boyle, Brendan F.
     Brown (MD)
     Brown (OH)
     Brownley
     Bush
     Butterfield
     Carbajal
     Cardenas
     Carson
     Carter (LA)
     Cartwright
     Casten
     Castor (FL)
     Castro (TX)
     Cherfilus-McCormick
     Chu
     Cicilline
     Clark (MA)
     Clarke (NY)
     Cleaver
     Clyburn
     Cohen
     Connolly
     Cooper
     Correa
     Costa
     Courtney
     Craig
     Crist

[[Page H4112]]


     Crow
     Cuellar
     Davids (KS)
     Davis, Danny K.
     Dean
     DeFazio
     DeGette
     DeLauro
     DelBene
     Delgado
     DeSaulnier
     Deutch
     Dingell
     Doggett
     Doyle, Michael F.
     Escobar
     Eshoo
     Espaillat
     Evans
     Fletcher
     Foster
     Frankel, Lois
     Gaetz
     Gallego
     Garamendi
     Garcia (IL)
     Garcia (TX)
     Golden
     Gomez
     Gonzalez, Vicente
     Green, Al (TX)
     Grijalva
     Harder (CA)
     Hayes
     Higgins (NY)
     Himes
     Horsford
     Houlahan
     Hoyer
     Huffman
     Jackson Lee
     Jacobs (CA)
     Jayapal
     Jeffries
     Johnson (GA)
     Johnson (TX)
     Jones
     Kahele
     Kaptur
     Keating
     Kelly (IL)
     Khanna
     Kildee
     Kilmer
     Kim (NJ)
     Kind
     Kirkpatrick
     Krishnamoorthi
     Kuster
     Lamb
     Langevin
     Larsen (WA)
     Larson (CT)
     Lawrence
     Lawson (FL)
     Lee (CA)
     Leger Fernandez
     Levin (CA)
     Levin (MI)
     Lieu
     Lofgren
     Lowenthal
     Luria
     Lynch
     Mace
     Maloney, Carolyn B.
     Maloney, Sean
     Manning
     Matsui
     McBath
     McCollum
     McEachin
     McGovern
     McNerney
     Meeks
     Meng
     Mfume
     Moore (WI)
     Morelle
     Moulton
     Mrvan
     Nadler
     Napolitano
     Neal
     Neguse
     Newman
     Norcross
     Ocasio-Cortez
     Omar
     Pallone
     Pappas
     Pascrell
     Payne
     Perlmutter
     Peters
     Phillips
     Pingree
     Pocan
     Porter
     Pressley
     Price (NC)
     Quigley
     Raskin
     Rice (NY)
     Ross
     Roybal-Allard
     Ruiz
     Ruppersberger
     Rush
     Ryan
     Sanchez
     Sarbanes
     Scanlon
     Schakowsky
     Schiff
     Schneider
     Schrader
     Scott (VA)
     Scott, David
     Sewell
     Sherman
     Sherrill
     Sires
     Smith (WA)
     Soto
     Speier
     Stansbury
     Stanton
     Stevens
     Strickland
     Suozzi
     Swalwell
     Takano
     Thompson (CA)
     Thompson (MS)
     Titus
     Tlaib
     Tonko
     Torres (CA)
     Torres (NY)
     Trahan
     Trone
     Underwood
     Vargas
     Veasey
     Velazquez
     Wasserman Schultz
     Waters
     Watson Coleman
     Welch
     Wild
     Williams (GA)
     Wilson (FL)
     Yarmuth

                               NAYS--214

     Aderholt
     Allen
     Amodei
     Armstrong
     Arrington
     Babin
     Bacon
     Baird
     Balderson
     Banks
     Barr
     Bentz
     Bergman
     Bice (OK)
     Biggs
     Bilirakis
     Bishop (NC)
     Boebert
     Bost
     Brady
     Brooks
     Buchanan
     Buck
     Bucshon
     Burchett
     Burgess
     Calvert
     Cammack
     Carey
     Carl
     Carter (GA)
     Carter (TX)
     Case
     Cawthorn
     Chabot
     Cline
     Cloud
     Clyde
     Cole
     Comer
     Crawford
     Crenshaw
     Curtis
     Davidson
     Davis, Rodney
     Demings
     DesJarlais
     Diaz-Balart
     Donalds
     Duncan
     Dunn
     Ellzey
     Emmer
     Estes
     Fallon
     Feenstra
     Ferguson
     Fischbach
     Fitzgerald
     Fitzpatrick
     Fleischmann
     Foxx
     Franklin, C. Scott
     Fulcher
     Gallagher
     Garbarino
     Garcia (CA)
     Gibbs
     Gimenez
     Gohmert
     Gonzales, Tony
     Good (VA)
     Gooden (TX)
     Gosar
     Gottheimer
     Granger
     Graves (LA)
     Graves (MO)
     Green (TN)
     Greene (GA)
     Griffith
     Grothman
     Guest
     Guthrie
     Harris
     Harshbarger
     Hartzler
     Hern
     Herrell
     Herrera Beutler
     Hice (GA)
     Higgins (LA)
     Hill
     Hinson
     Hollingsworth
     Hudson
     Huizenga
     Issa
     Jackson
     Jacobs (NY)
     Johnson (OH)
     Johnson (SD)
     Jordan
     Joyce (OH)
     Joyce (PA)
     Katko
     Keller
     Kelly (MS)
     Kelly (PA)
     Kim (CA)
     Kustoff
     LaHood
     LaMalfa
     Lamborn
     Latta
     LaTurner
     Lee (NV)
     Lesko
     Letlow
     Long
     Loudermilk
     Lucas
     Luetkemeyer
     Malinowski
     Malliotakis
     Mann
     Massie
     Mast
     McCarthy
     McCaul
     McClain
     McClintock
     McHenry
     McKinley
     Meijer
     Meuser
     Miller (IL)
     Miller (WV)
     Miller-Meeks
     Moolenaar
     Mooney
     Moore (AL)
     Moore (UT)
     Mullin
     Murphy (FL)
     Murphy (NC)
     Nehls
     Newhouse
     Norman
     O'Halleran
     Obernolte
     Owens
     Palazzo
     Palmer
     Panetta
     Pence
     Perry
     Pfluger
     Posey
     Reed
     Reschenthaler
     Rice (SC)
     Rodgers (WA)
     Rogers (AL)
     Rogers (KY)
     Rose
     Rosendale
     Rouzer
     Roy
     Rutherford
     Salazar
     Scalise
     Schrier
     Schweikert
     Scott, Austin
     Sessions
     Simpson
     Slotkin
     Smith (MO)
     Smith (NE)
     Smith (NJ)
     Smucker
     Spanberger
     Spartz
     Stauber
     Steel
     Stefanik
     Steil
     Steube
     Stewart
     Taylor
     Tenney
     Thompson (PA)
     Tiffany
     Timmons
     Turner
     Upton
     Valadao
     Van Drew
     Van Duyne
     Wagner
     Walberg
     Walorski
     Waltz
     Weber (TX)
     Webster (FL)
     Wenstrup
     Westerman
     Wexton
     Williams (TX)
     Wilson (SC)
     Wittman
     Womack
     Zeldin

                             NOT VOTING--6

     Budd
     Bustos
     Cheney
     Gonzalez (OH)
     Johnson (LA)
     Kinzinger

                              {time}  1200

  So the amendment was rejected.
  The result of the vote was announced as above recorded.


    MEMBERS RECORDED PURSUANT TO HOUSE RESOLUTION 8, 117TH CONGRESS

     Armstrong (Resch-enthaler)
     Baird (Walorski)
     Barragan (Correa)
     Bass (Blunt Rochester)
     Bilirakis (Fleischmann)
     Bowman (Evans)
     Brooks (Fleischmann)
     Brown (OH) (Beyer)
     Cawthorn (Gaetz)
     Clarke (NY) (Velazquez)
     Cooper (Correa)
     Comer (Fleischmann)
     Crist (Wasserman Schultz)
     Cuellar (Pappas)
     Curtis (Moore (UT))
     Davis, Danny K. (Gomez)
     DeGette (Blunt Rochester)
     Deutch (Rice (NY))
     Donalds (Cammack)
     Espaillat (Correa)
     Ferguson (Kustoff)
     Frankel, Lois (Wasserman Schultz)
     Garcia (IL) (Takano)
     Garcia (TX) (Gomez)
     Gimenez (Diaz-Balart)
     Green (TN) (Fleischmann)
     Harder (CA) (Gomez)
     Jayapal (Gomez)
     Johnson (TX) (Beyer)
     Joyce (OH) (Garbarino)
     Kahele (Takano)
     Katko (Garbarino)
     Kelly (IL) (Blunt Rochester)
     Kind (Beyer)
     Kirkpatrick (Pallone)
     Krishnamoorthi (Beyer)
     LaMalfa (Palazzo)
     Lawson (FL) (Wasserman Schultz)
     Long (Fleischmann)
     Luetkemeyer (Meuser)
     Mace (Timmons)
     Manning (Beyer)
     McClain (Fitzgerald)
     McEachin (Wexton)
     McHenry (Rouzer)
     Meng (Kuster)
     Newman (Beyer)
     Owens (Moore (UT))
     Panetta (Gomez)
     Price (NC) (Connolly)
     Rice (SC) (Meijer)
     Roybal-Allard (Wasserman Schultz)
     Ryan (Kaptur)
     Salazar (Steube)
     Sanchez (Gomez)
     Scott, David (Correa)
     Sessions (Babin)
     Sires (Pallone)
     Speier (Scanlon)
     Steel (Obernolte)
     Stewart (Moore (UT))
     Strickland (Takano)
     Suozzi (Beyer)
     Taylor (Carter (TX))
     Thompson (MS) (Evans)
     Trone (Beyer)
     Waltz (Mast)
     Wilson (FL) (Evans)
     Wilson (SC) (Timmons)
       


 =========================== NOTE =========================== 

  
  April 1, 2022, on page H4112 (second column), the following 
appeared: Thompson (MS) (Evans) Trone (Beyer) Waltz (Mast) Wilson 
(FL) (Evans) Wilson (SC) --------------------
  
  The online version has been corrected to read: Thompson (MS) 
(Evans) Trone (Beyer) Waltz (Mast) Wilson (FL) (Evans) Wilson (SC) 
(Timmons)


 ========================= END NOTE ========================= 


  The SPEAKER pro tempore. The previous question is ordered on the 
bill, as amended.
  The question is on the engrossment and third reading of the bill.
  The bill was ordered to be engrossed and read a third time, and was 
read the third time.


                           Motion to Recommit

  Mr. LATTA. Madam Speaker, I have a motion to recommit at the desk.
  The SPEAKER pro tempore. The Clerk will report the motion to 
recommit.
  The Clerk read as follows:

       Mr. Latta moves to recommit the bill H.R. 3617 to the 
     Committee on the Judiciary.

  The material previously referred to by Mr. Latta is as follows:

       At the end of the Rules Committee Print, add the following 
     (and make such conforming changes as may be necessary):

           TITLE II--HALT ALL LETHAL TRAFFICKING OF FENTANYL

     SEC. 201. SHORT TITLE.

       This title may be cited as the ``Halt All Lethal 
     Trafficking of Fentanyl Act'' or the ``HALT Fentanyl Act''.

     SEC. 202. CLASS SCHEDULING OF FENTANYL-RELATED SUBSTANCES.

       Section 202(c) of the Controlled Substances Act (21 U.S.C. 
     812(c)) is amended by adding at the end of schedule I the 
     following:
       ``(e)(1) Unless specifically exempted or unless listed in 
     another schedule, any material, compound, mixture, or 
     preparation which contains any quantity of a fentanyl-related 
     substance, or which contains the salts, isomers, and salts of 
     isomers of a fentanyl-related substance whenever the 
     existence of such salts, isomers, and salts of isomers is 
     possible within the specific chemical designation.
       ``(2) For purposes of paragraph (1), except as provided in 
     paragraph (3), the term `fentanyl-related substance' means 
     any substance that is structurally related to fentanyl by 1 
     or more of the following modifications:
       ``(A) By replacement of the phenyl portion of the phenethyl 
     group by any monocycle, whether or not further substituted in 
     or on the monocycle.
       ``(B) By substitution in or on the phenethyl group with 
     alkyl, alkenyl, alkoxyl, hydroxyl, halo, haloalkyl, amino, or 
     nitro groups.
       ``(C) By substitution in or on the piperidine ring with 
     alkyl, alkenyl, alkoxyl, ester, ether, hydroxyl, halo, 
     haloalkyl, amino, or nitro groups.
       ``(D) By replacement of the aniline ring with any aromatic 
     monocycle whether or not further substituted in or on the 
     aromatic monocycle.
       ``(E) By replacement of the N-propionyl group with another 
     acyl group.
       ``(3) A substance that satisfies the definition of the term 
     `fentanyl-related substance' in paragraph (2) shall 
     nonetheless not be treated as a fentanyl-related substance 
     subject to this schedule if the substance--
       ``(A) is controlled by action of the Attorney General under 
     section 201; or
       ``(B) is otherwise expressly listed in a schedule other 
     than this schedule.
       ``(4)(A) The Attorney General may by order publish in the 
     Federal Register a list of substances that satisfy the 
     definition of the term `fentanyl-related substance' in 
     paragraph (2).
       ``(B) The absence of a substance from a list published 
     under subparagraph (A) does not negate the control status of 
     the substance under this schedule if the substance satisfies 
     the definition of the term `fentanyl-related substance' in 
     paragraph (2).''.

     SEC. 203. REGISTRATION REQUIREMENTS RELATED TO RESEARCH.

       (a) Alternative Registration Process for Schedule I 
     Research.--Section 303 of the Controlled Substances Act (21 
     U.S.C. 823) is amended by adding at the end the following:
       ``(l) Special Provisions for Practitioners Conducting 
     Certain Research With Schedule I Controlled Substances.--

[[Page H4113]]

       ``(1) In general.--Notwithstanding subsection (f), a 
     practitioner may conduct research described in paragraph (2) 
     of this subsection with 1 or more schedule I substances in 
     accordance with subparagraph (A) or (B) of paragraph (3) of 
     this subsection.
       ``(2) Research subject to expedited procedures.--Research 
     described in this paragraph is research that--
       ``(A) is with respect to a drug that is the subject of an 
     investigational use exemption under section 505(i) of the 
     Federal Food, Drug, and Cosmetic Act; or
       ``(B) is--
       ``(i) conducted by the Department of Health and Human 
     Services or the Department of Veterans Affairs; or
       ``(ii) funded partly or entirely by a grant, contract, 
     cooperative agreement, or other transaction from the 
     Department of Health and Human Services or the Department of 
     Veterans Affairs.
       ``(3) Expedited procedures.--
       ``(A) Researcher with a current schedule i or ii research 
     registration.--
       ``(i) In general.--If a practitioner is registered to 
     conduct research with a controlled substance in schedule I or 
     II, the practitioner may conduct research under this 
     subsection on and after the date that is 30 days after the 
     date on which the practitioner sends a notice to the Attorney 
     General containing the following information, with respect to 
     each substance with which the practitioner will conduct the 
     research:

       ``(I) The chemical name of the substance.
       ``(II) The quantity of the substance to be used in the 
     research.
       ``(III) Demonstration that the research is in the category 
     described in paragraph (2), which demonstration may be 
     satisfied--

       ``(aa) in the case of a grant, contract, cooperative 
     agreement, or other transaction, or intramural research 
     project, by identifying the sponsoring agency and supplying 
     the number of the grant, contract, cooperative agreement, 
     other transaction, or project; or
       ``(bb) in the case of an application under section 505(i) 
     of the Federal Food, Drug, and Cosmetic Act, by supplying the 
     application number and the sponsor of record on the 
     application.

       ``(IV) Demonstration that the researcher is authorized to 
     conduct research with respect to the substance under the laws 
     of the State in which the research will take place.

       ``(ii) Verification of information by hhs or va.--Upon 
     request from the Attorney General, the Secretary of Health 
     and Human Services or the Secretary of Veterans Affairs, as 
     appropriate, shall verify information submitted by an 
     applicant under clause (i)(III).
       ``(B) Researcher without a current schedule i or ii 
     research registration.--
       ``(i) In general.--If a practitioner is not registered to 
     conduct research with a controlled substance in schedule I or 
     II, the practitioner may send a notice to the Attorney 
     General containing the information listed in subparagraph 
     (A)(i), with respect to each substance with which the 
     practitioner will conduct the research.
       ``(ii) Attorney general action.--The Attorney General 
     shall--

       ``(I) treat notice received under clause (i) as a 
     sufficient application for a research registration; and
       ``(II) not later than 45 days of receiving such a notice 
     that contains all information required under subparagraph 
     (A)(i)--

       ``(aa) register the applicant; or
       ``(bb) serve an order to show cause upon the applicant in 
     accordance with section 304(c).
       ``(4) Electronic submissions.--The Attorney General shall 
     provide a means to permit a practitioner to submit a 
     notification under paragraph (3) electronically.
       ``(5) Limitation on amounts.--A practitioner conducting 
     research with a schedule I substance under this subsection 
     may only possess the amounts of schedule I substance 
     identified in--
       ``(A) the notification to the Attorney General under 
     paragraph (3); or
       ``(B) a supplemental notification that the practitioner may 
     send if the practitioner needs additional amounts for the 
     research, which supplemental notification shall include--
       ``(i) the name of the practitioner;
       ``(ii) the additional quantity needed of the substance; and
       ``(iii) an attestation that the research to be conducted 
     with the substance is consistent with the scope of the 
     research that was the subject of the notification under 
     paragraph (3).
       ``(6) Importation and exportation requirements not 
     affected.--Nothing in this subsection alters the requirements 
     of part A of title III, regarding the importation and 
     exportation of controlled substances.''.
       (b) Separate Registrations Not Required for Additional 
     Researcher in Same Institution.--Section 302(c) of the 
     Controlled Substances Act (21 U.S.C. 822(c)) is amended by 
     adding at the end the following:
       ``(4) An agent or employee of a research institution that 
     is conducting research with a controlled substance if--
       ``(A) the agent or employee is acting within the scope of 
     the professional practice of the agent or employee;
       ``(B) another agent or employee of the institution is 
     registered to conduct research with a controlled substance in 
     the same schedule;
       ``(C) the researcher who is so registered--
       ``(i) informs the Attorney General of the name, position 
     title, and employing institution of the agent or employee who 
     is not separately registered;
       ``(ii) authorizes that agent or employee to perform 
     research under the registration of the registered researcher; 
     and
       ``(iii) affirms that any act taken by that agent or 
     employee involving a controlled substance shall be 
     attributable to the registered researcher, as if the 
     researcher had directly committed the act, for purposes of 
     any proceeding under section 304(a) to suspend or revoke the 
     registration of the registered researcher; and
       ``(D) the Attorney General does not, within 30 days of 
     receiving the information, authorization, and affirmation 
     described in subparagraph (C), refuse, for a reason listed in 
     section 304(a), to allow the agent or employee to possess the 
     substance without a separate registration.''.
       (c) Single Registration for Related Research Sites.--
     Section 302(e) of the Controlled Substances Act (21 U.S.C. 
     822(e)) is amended by adding at the end the following:
       ``(3)(A) Notwithstanding paragraph (1), a person registered 
     to conduct research with a controlled substance under section 
     303(f) may conduct the research under a single registration 
     if--
       ``(i) the research occurs exclusively on sites all of which 
     are--
       ``(I) within the same city or county; and
       ``(II) under the control of the same institution, 
     organization, or agency; and
       ``(ii) before commencing the research, the researcher 
     notifies the Attorney General of each site where--
       ``(I) the research will be conducted; or
       ``(II) the controlled substance will be stored or 
     administered.
       ``(B) A site described in subparagraph (A) shall be 
     included in a registration described in that subparagraph 
     only if the researcher has notified the Attorney General of 
     the site--
       ``(i) in the application for the registration; or
       ``(ii) before the research is conducted, or before the 
     controlled substance is stored or administered, at the site.
       ``(C) The Attorney General may, in consultation with the 
     Secretary, issue regulations addressing, with respect to 
     research sites described in subparagraph (A)--
       ``(i) the manner in which controlled substances may be 
     delivered to the research sites;
       ``(ii) the storage and security of controlled substances at 
     the research sites;
       ``(iii) the maintenance of records for the research sites; 
     and
       ``(iv) any other matters necessary to ensure effective 
     controls against diversion at the research sites.''.
       (d) New Inspection Not Required in Certain Situations.--
     Section 302(f) of the Controlled Substances Act (21 U.S.C. 
     822(f)) is amended--
       (1) by striking ``(f) The'' and inserting ``(f)(1) The''; 
     and
       (2) by adding at the end the following:
       ``(2)(A) If a person is registered to conduct research with 
     a controlled substance and applies for a registration, or for 
     a modification of a registration, to conduct research with a 
     second controlled substance that is in the same schedule as 
     the first controlled substance, or is in a schedule with a 
     higher numerical designation than the schedule of the first 
     controlled substance, a new inspection by the Attorney 
     General of the registered location is not required.
       ``(B) Nothing in subparagraph (A) shall prohibit the 
     Attorney General from conducting an inspection that the 
     Attorney General determines necessary to ensure that a 
     registrant maintains effective controls against diversion.''.
       (e) Continuation of Research on Substances Newly Added to 
     Schedule I.--Section 302 of the Controlled Substances Act (21 
     U.S.C. 822) is amended by adding at the end the following:
       ``(h) Continuation of Research on Substances Newly Added to 
     Schedule I.--If a person is conducting research on a 
     substance when the substance is added to schedule I, and the 
     person is already registered to conduct research with a 
     controlled substance in schedule I--
       ``(1) not later than 90 days after the scheduling of the 
     newly scheduled substance, the person shall submit a 
     completed application for registration or modification of 
     existing registration, to conduct research on the substance, 
     in accordance with regulations issued by the Attorney General 
     for purposes of this paragraph;
       ``(2) the person may, notwithstanding subsections (a) and 
     (b), continue to conduct the research on the substance 
     until--
       ``(A) the person withdraws the application described in 
     paragraph (1) of this subsection; or
       ``(B) the Attorney General serves on the person an order to 
     show cause proposing the denial of the application under 
     section 304(c);
       ``(3) if the Attorney General serves an order to show cause 
     as described in paragraph (2)(B) and the person requests a 
     hearing, the hearing shall be held on an expedited basis and 
     not later than 45 days after the request is made, except that 
     the hearing may be held at a later time if so requested by 
     the person; and
       ``(4) if the person sends a copy of the application 
     described in paragraph (1) to a manufacturer or distributor 
     of the substance, receipt of the copy by the manufacturer or 
     distributor shall constitute sufficient evidence that the 
     person is authorized to receive the substance.''.

[[Page H4114]]

       (f) Treatment of Certain Manufacturing Activities as 
     Coincident to Research.--Section 302 of the Controlled 
     Substances Act (21 U.S.C. 822), as amended by subsection (e), 
     is amended by adding at the end the following:
       ``(i) Treatment of Certain Manufacturing Activities as 
     Coincident to Research.--
       ``(1) In general.--Except as provided in paragraph (3), a 
     person who is registered to perform research on a controlled 
     substance may perform manufacturing activities with small 
     quantities of that substance, including activities described 
     in paragraph (2), without being required to obtain a 
     manufacturing registration, if--
       ``(A) the activities are performed for the purpose of the 
     research; and
       ``(B) the activities and the quantities of the substance 
     involved in the activities are stated in--
       ``(i) a notification submitted to the Attorney General 
     under section 303(l);
       ``(ii) a research protocol filed with an application for 
     registration approval under section 303(f); or
       ``(iii) a notification to the Attorney General that 
     includes--

       ``(I) the name of the registrant; and
       ``(II) an attestation that the research to be conducted 
     with the small quantities of manufactured substance is 
     consistent with the scope of the research that is the basis 
     for the registration.

       ``(2) Activities included.--Activities permitted under 
     paragraph (1) include--
       ``(A) processing the substance to create extracts, 
     tinctures, oils, solutions, derivatives, or other forms of 
     the substance consistent with--
       ``(i) the information provided as part of a notification 
     submitted to the Attorney General under section 303(l); or
       ``(ii) a research protocol filed with an application for 
     registration approval under section 303(f); and
       ``(B) dosage form development studies performed for the 
     purpose of requesting an investigational new drug exemption 
     under section 505(i) of the Federal Food, Drug, and Cosmetic 
     Act (21 U.S.C. 355(i)).
       ``(3) Exception regarding marihuana.--The authority under 
     paragraph (1) to manufacture substances does not include the 
     authority to grow marihuana.''.
       (g) Transparency Regarding Special Procedures.--Section 303 
     of the Controlled Substances Act (21 U.S.C. 823), as amended 
     by subsection (a), is amended by adding at the end the 
     following:
       ``(m) Transparency Regarding Special Procedures.--
       ``(1) In general.--If the Attorney General determines, with 
     respect to a controlled substance, that an application by a 
     practitioner to conduct research with the substance should be 
     considered under a process, or subject to criteria, different 
     from the process or criteria applicable to applications to 
     conduct research with other controlled substances in the same 
     schedule, the Attorney General shall make public, including 
     by posting on the website of the Drug Enforcement 
     Administration--
       ``(A) the identities of all substances for which such 
     determinations have been made;
       ``(B) the process and criteria that shall be applied to 
     applications to conduct research with those substances; and
       ``(C) how the process and criteria described in 
     subparagraph (B) differ from the process and criteria 
     applicable to applications to conduct research with other 
     controlled substances in the same schedule.
       ``(2) Timing of posting.--The Attorney General shall make 
     information described in paragraph (1) public upon making a 
     determination described in that paragraph, regardless of 
     whether a practitioner has submitted such an application at 
     that time.''.

     SEC. 204. RULEMAKING.

       (a) Interim Final Rules.--The Attorney General--
       (1) shall, not later than 1 year of the date of enactment 
     of this title, issue rules to implement this title and the 
     amendments made by this title; and
       (2) may issue the rules under paragraph (1) as interim 
     final rules.
       (b) Procedure for Final Rule.--
       (1) Effectiveness of interim final rules.--A rule issued by 
     the Attorney General as an interim final rule under 
     subsection (a) shall become immediately effective as an 
     interim final rule without requiring the Attorney General to 
     demonstrate good cause therefor, notwithstanding subparagraph 
     (B) of section 553(b) of title 5, United States Code.
       (2) Opportunity for comment and hearing.--An interim final 
     rule issued under subsection (a) shall give interested 
     persons the opportunity to comment and to request a hearing.
       (3) Final rule.--After the conclusion of such proceedings, 
     the Attorney General shall issue a final rule to implement 
     this title and the amendments made by this title in 
     accordance with section 553 of title 5, United States Code.

  The SPEAKER pro tempore. Pursuant to clause 2(b) of rule XIX, the 
previous question is ordered on the motion to recommit.
  The question is on the motion to recommit.
  The question was taken; and the Speaker pro tempore announced that 
the noes appeared to have it.
  Mr. LATTA. Madam Speaker, on that I demand the yeas and nays.
  The SPEAKER pro tempore. Pursuant to section 3(s) of House Resolution 
8, the yeas and nays are ordered.
  The vote was taken by electronic device, and there were--yeas 202, 
nays 220, not voting 7, as follows:

                             [Roll No. 106]

                               YEAS--202

     Aderholt
     Allen
     Amodei
     Armstrong
     Arrington
     Babin
     Bacon
     Baird
     Balderson
     Banks
     Barr
     Bentz
     Bergman
     Bice (OK)
     Biggs
     Bilirakis
     Bishop (NC)
     Boebert
     Bost
     Brady
     Brooks
     Buchanan
     Buck
     Bucshon
     Burchett
     Burgess
     Calvert
     Cammack
     Carey
     Carl
     Carter (GA)
     Carter (TX)
     Cawthorn
     Chabot
     Cline
     Cloud
     Clyde
     Cole
     Comer
     Crawford
     Crenshaw
     Curtis
     Davidson
     Davis, Rodney
     DesJarlais
     Diaz-Balart
     Donalds
     Duncan
     Dunn
     Ellzey
     Emmer
     Estes
     Fallon
     Feenstra
     Ferguson
     Fischbach
     Fitzgerald
     Fitzpatrick
     Fleischmann
     Foxx
     Franklin, C. Scott
     Fulcher
     Gaetz
     Gallagher
     Garbarino
     Garcia (CA)
     Gibbs
     Gimenez
     Gohmert
     Gonzales, Tony
     Good (VA)
     Gooden (TX)
     Gosar
     Granger
     Graves (LA)
     Graves (MO)
     Green (TN)
     Greene (GA)
     Griffith
     Grothman
     Guest
     Guthrie
     Harris
     Harshbarger
     Hartzler
     Hern
     Herrell
     Herrera Beutler
     Hice (GA)
     Higgins (LA)
     Hill
     Hinson
     Hollingsworth
     Hudson
     Huizenga
     Issa
     Jackson
     Jacobs (NY)
     Johnson (OH)
     Johnson (SD)
     Jordan
     Joyce (OH)
     Joyce (PA)
     Katko
     Keller
     Kelly (MS)
     Kelly (PA)
     Kim (CA)
     Kustoff
     LaHood
     LaMalfa
     Lamborn
     Latta
     LaTurner
     Lesko
     Letlow
     Long
     Loudermilk
     Lucas
     Luetkemeyer
     Mace
     Malliotakis
     Mann
     Mast
     McCarthy
     McCaul
     McClain
     McClintock
     McHenry
     McKinley
     Meijer
     Meuser
     Miller (IL)
     Miller (WV)
     Miller-Meeks
     Moolenaar
     Mooney
     Moore (AL)
     Moore (UT)
     Mullin
     Murphy (NC)
     Nehls
     Newhouse
     Norman
     Obernolte
     Owens
     Palazzo
     Palmer
     Pence
     Perry
     Pfluger
     Posey
     Reed
     Reschenthaler
     Rice (SC)
     Rodgers (WA)
     Rogers (AL)
     Rogers (KY)
     Rose
     Rosendale
     Rouzer
     Roy
     Rutherford
     Salazar
     Scalise
     Schweikert
     Scott, Austin
     Sessions
     Simpson
     Smith (MO)
     Smith (NE)
     Smith (NJ)
     Smucker
     Spartz
     Stauber
     Steel
     Stefanik
     Steil
     Steube
     Stewart
     Taylor
     Tenney
     Thompson (PA)
     Tiffany
     Timmons
     Turner
     Upton
     Valadao
     Van Drew
     Van Duyne
     Wagner
     Walberg
     Walorski
     Waltz
     Weber (TX)
     Webster (FL)
     Wenstrup
     Westerman
     Williams (TX)
     Wilson (SC)
     Wittman
     Womack

                               NAYS--220

     Adams
     Aguilar
     Allred
     Auchincloss
     Axne
     Barragan
     Bass
     Beatty
     Bera
     Beyer
     Bishop (GA)
     Blumenauer
     Blunt Rochester
     Bonamici
     Bourdeaux
     Bowman
     Boyle, Brendan F.
     Brown (MD)
     Brown (OH)
     Brownley
     Bush
     Butterfield
     Carbajal
     Cardenas
     Carson
     Carter (LA)
     Cartwright
     Case
     Casten
     Castor (FL)
     Castro (TX)
     Cherfilus-McCormick
     Chu
     Cicilline
     Clark (MA)
     Clarke (NY)
     Cleaver
     Clyburn
     Cohen
     Connolly
     Cooper
     Correa
     Costa
     Courtney
     Craig
     Crist
     Crow
     Cuellar
     Davids (KS)
     Davis, Danny K.
     Dean
     DeFazio
     DeGette
     DeLauro
     DelBene
     Delgado
     Demings
     DeSaulnier
     Deutch
     Dingell
     Doggett
     Doyle, Michael F.
     Escobar
     Eshoo
     Espaillat
     Evans
     Fletcher
     Foster
     Frankel, Lois
     Gallego
     Garamendi
     Garcia (IL)
     Garcia (TX)
     Golden
     Gomez
     Gonzalez, Vicente
     Gottheimer
     Green, Al (TX)
     Grijalva
     Harder (CA)
     Hayes
     Higgins (NY)
     Himes
     Horsford
     Houlahan
     Hoyer
     Huffman
     Jackson Lee
     Jacobs (CA)
     Jayapal
     Jeffries
     Johnson (GA)
     Johnson (TX)
     Jones
     Kahele
     Kaptur
     Keating
     Kelly (IL)
     Khanna
     Kildee
     Kilmer
     Kim (NJ)
     Kind
     Kirkpatrick
     Krishnamoorthi
     Kuster
     Lamb
     Langevin
     Larsen (WA)
     Larson (CT)
     Lawrence
     Lawson (FL)
     Lee (CA)
     Lee (NV)
     Leger Fernandez
     Levin (CA)
     Levin (MI)
     Lieu
     Lofgren
     Lowenthal
     Luria
     Lynch
     Malinowski
     Maloney, Carolyn B.
     Maloney, Sean
     Manning
     Massie
     Matsui
     McBath
     McCollum
     McEachin
     McGovern
     McNerney
     Meeks
     Meng
     Mfume
     Moore (WI)
     Morelle
     Moulton
     Mrvan
     Murphy (FL)
     Nadler
     Napolitano
     Neal
     Neguse
     Newman
     Norcross
     O'Halleran
     Ocasio-Cortez
     Omar
     Pallone
     Panetta
     Pappas
     Pascrell
     Payne
     Perlmutter
     Peters
     Phillips
     Pingree
     Pocan
     Porter
     Pressley
     Price (NC)
     Quigley
     Raskin
     Rice (NY)
     Ross
     Roybal-Allard
     Ruiz
     Ruppersberger
     Rush
     Ryan
     Sanchez
     Sarbanes
     Scanlon
     Schakowsky
     Schiff
     Schneider
     Schrader
     Schrier
     Scott (VA)
     Scott, David
     Sewell
     Sherman
     Sherrill
     Sires
     Slotkin
     Smith (WA)
     Soto
     Spanberger

[[Page H4115]]


     Speier
     Stansbury
     Stanton
     Stevens
     Strickland
     Suozzi
     Swalwell
     Takano
     Thompson (CA)
     Thompson (MS)
     Titus
     Tlaib
     Tonko
     Torres (CA)
     Torres (NY)
     Trahan
     Trone
     Underwood
     Vargas
     Veasey
     Velazquez
     Wasserman Schultz
     Waters
     Watson Coleman
     Welch
     Wexton
     Wild
     Williams (GA)
     Wilson (FL)
     Yarmuth

                             NOT VOTING--7

     Budd
     Bustos
     Cheney
     Gonzalez (OH)
     Johnson (LA)
     Kinzinger
     Zeldin

                              {time}  1215

  Mr. BROWN of Maryland changed his vote from ``yea'' to ``nay.''
  So the motion to recommit was rejected.
  The result of the vote was announced as above recorded.


    MEMBERS RECORDED PURSUANT TO HOUSE RESOLUTION 8, 117TH CONGRESS

     Armstrong
     (Reschenthaler)
     Baird (Walorski)
     Barragan (Correa)
     Bass (Blunt Rochester)
     Bilirakis (Fleischmann)
     Bowman (Evans)
     Brooks (Fleischmann)
     Brown (OH) (Beyer)
     Cawthorn (Gaetz)
     Clarke (NY) (Velazquez)
     Cooper (Correa)
     Comer (Fleischmann)
     Crist (Wasserman Schultz)
     Cuellar (Pappas)
     Curtis (Moore (UT))
     Davis, Danny K. (Gomez)
     DeGette (Blunt Rochester)
     Deutch (Rice (NY))
     Donalds (Cammack)
     Espaillat (Correa)
     Ferguson (Kustoff)
     Frankel, Lois (Wasserman Schultz)
     Garcia (IL) (Takano)
     Garcia (TX) (Gomez)
     Gimenez (Diaz-Balart)
     Green (TN) (Fleischmann)
     Harder (CA) (Gomez)
     Jayapal (Gomez)
     Johnson (TX) (Beyer)
     Joyce (OH) (Garbarino)
     Kahele (Takano)
     Katko (Garbarino)
     Kelly (IL) (Blunt Rochester)
     Kind (Beyer)
     Kirkpatrick (Pallone)
     Krishnamoorthi (Beyer)
     LaMalfa (Palazzo)
     Lawson (FL) (Wasserman Schultz)
     Long (Fleischmann)
     Luetkemeyer (Meuser)
     Mace (Timmons)
     Manning (Beyer)
     McClain (Fitzgerald)
     McEachin (Wexton)
     McHenry (Rouzer)
     Meng (Kuster)
     Newman (Beyer)
     Owens (Moore (UT))
     Panetta (Gomez)
     Price (NC) (Connolly)
     Rice (SC) (Meijer)
     Roybal-Allard (Wasserman Schultz)
     Ryan (Kaptur)
     Salazar (Steube)
     Sanchez (Gomez)
     Scott, David (Correa)
     Sessions (Babin)
     Sires (Pallone)
     Speier (Scanlon)
     Steel (Obernolte)
     Stewart (Moore (UT))
     Strickland (Takano)
     Suozzi (Beyer)
     Taylor (Carter (TX))
     Thompson (MS) (Evans)
     Trone (Beyer)
     Waltz (Mast)
     Wilson (FL) (Evans)
     Wilson (SC) (Timmons)
  The SPEAKER pro tempore. The question is on the passage of the bill.
  The question was taken; and the Speaker pro tempore announced that 
the ayes appeared to have it.
  Mr. BENTZ. Madam Speaker, on that I demand the yeas and nays.
  The SPEAKER pro tempore. Pursuant to section 3(s) of House Resolution 
8, the yeas and nays are ordered.
  This will be a 5-minute vote.
  The vote was taken by electronic device, and there were--yeas 220, 
nays 204, not voting 5, as follows:

                             [Roll No. 107]

                               YEAS--220

     Adams
     Aguilar
     Allred
     Auchincloss
     Axne
     Barragan
     Bass
     Beatty
     Bera
     Beyer
     Bishop (GA)
     Blumenauer
     Blunt Rochester
     Bonamici
     Bourdeaux
     Bowman
     Boyle, Brendan F.
     Brown (MD)
     Brown (OH)
     Brownley
     Bush
     Butterfield
     Carbajal
     Cardenas
     Carson
     Carter (LA)
     Cartwright
     Case
     Casten
     Castor (FL)
     Castro (TX)
     Cherfilus-McCormick
     Chu
     Cicilline
     Clark (MA)
     Clarke (NY)
     Cleaver
     Clyburn
     Cohen
     Connolly
     Cooper
     Correa
     Costa
     Courtney
     Craig
     Crist
     Crow
     Davids (KS)
     Davis, Danny K.
     Dean
     DeFazio
     DeGette
     DeLauro
     DelBene
     Delgado
     Demings
     DeSaulnier
     Deutch
     Dingell
     Doggett
     Doyle, Michael F.
     Escobar
     Eshoo
     Espaillat
     Evans
     Fletcher
     Foster
     Frankel, Lois
     Gaetz
     Gallego
     Garamendi
     Garcia (IL)
     Garcia (TX)
     Golden
     Gomez
     Gonzalez, Vicente
     Gottheimer
     Green, Al (TX)
     Grijalva
     Harder (CA)
     Hayes
     Higgins (NY)
     Himes
     Horsford
     Houlahan
     Hoyer
     Huffman
     Jackson Lee
     Jacobs (CA)
     Jayapal
     Jeffries
     Johnson (GA)
     Johnson (TX)
     Jones
     Kahele
     Kaptur
     Keating
     Kelly (IL)
     Khanna
     Kildee
     Kilmer
     Kim (NJ)
     Kind
     Kirkpatrick
     Krishnamoorthi
     Kuster
     Lamb
     Langevin
     Larsen (WA)
     Larson (CT)
     Lawrence
     Lawson (FL)
     Lee (CA)
     Lee (NV)
     Leger Fernandez
     Levin (CA)
     Levin (MI)
     Lieu
     Lofgren
     Lowenthal
     Luria
     Lynch
     Malinowski
     Maloney, Carolyn B.
     Maloney, Sean
     Manning
     Mast
     Matsui
     McBath
     McClintock
     McCollum
     McEachin
     McGovern
     McNerney
     Meeks
     Meng
     Mfume
     Moore (WI)
     Morelle
     Moulton
     Mrvan
     Murphy (FL)
     Nadler
     Napolitano
     Neal
     Neguse
     Newman
     Norcross
     O'Halleran
     Ocasio-Cortez
     Omar
     Pallone
     Panetta
     Pascrell
     Payne
     Perlmutter
     Peters
     Phillips
     Pingree
     Pocan
     Porter
     Pressley
     Price (NC)
     Quigley
     Raskin
     Rice (NY)
     Ross
     Roybal-Allard
     Ruiz
     Ruppersberger
     Rush
     Ryan
     Sanchez
     Sarbanes
     Scanlon
     Schakowsky
     Schiff
     Schneider
     Schrader
     Schrier
     Scott (VA)
     Scott, David
     Sewell
     Sherman
     Sherrill
     Sires
     Slotkin
     Smith (WA)
     Soto
     Spanberger
     Speier
     Stansbury
     Stanton
     Stevens
     Strickland
     Suozzi
     Swalwell
     Takano
     Thompson (CA)
     Thompson (MS)
     Titus
     Tlaib
     Tonko
     Torres (CA)
     Torres (NY)
     Trahan
     Trone
     Underwood
     Vargas
     Veasey
     Velazquez
     Wasserman Schultz
     Waters
     Watson Coleman
     Welch
     Wexton
     Wild
     Williams (GA)
     Wilson (FL)
     Yarmuth

                               NAYS--204

     Aderholt
     Allen
     Amodei
     Armstrong
     Arrington
     Babin
     Bacon
     Baird
     Balderson
     Banks
     Barr
     Bentz
     Bergman
     Bice (OK)
     Biggs
     Bilirakis
     Bishop (NC)
     Boebert
     Bost
     Brady
     Brooks
     Buchanan
     Buck
     Bucshon
     Burchett
     Burgess
     Calvert
     Cammack
     Carey
     Carl
     Carter (GA)
     Carter (TX)
     Cawthorn
     Chabot
     Cline
     Cloud
     Clyde
     Cole
     Comer
     Crawford
     Crenshaw
     Cuellar
     Curtis
     Davidson
     Davis, Rodney
     DesJarlais
     Diaz-Balart
     Donalds
     Duncan
     Dunn
     Ellzey
     Emmer
     Estes
     Fallon
     Feenstra
     Ferguson
     Fischbach
     Fitzgerald
     Fitzpatrick
     Fleischmann
     Foxx
     Franklin, C. Scott
     Fulcher
     Gallagher
     Garbarino
     Garcia (CA)
     Gibbs
     Gimenez
     Gohmert
     Gonzales, Tony
     Gonzalez (OH)
     Good (VA)
     Gooden (TX)
     Gosar
     Granger
     Graves (LA)
     Graves (MO)
     Green (TN)
     Greene (GA)
     Griffith
     Grothman
     Guest
     Guthrie
     Harris
     Harshbarger
     Hartzler
     Hern
     Herrell
     Herrera Beutler
     Hice (GA)
     Higgins (LA)
     Hill
     Hinson
     Hollingsworth
     Hudson
     Huizenga
     Issa
     Jackson
     Jacobs (NY)
     Johnson (OH)
     Johnson (SD)
     Jordan
     Joyce (OH)
     Joyce (PA)
     Katko
     Keller
     Kelly (MS)
     Kelly (PA)
     Kim (CA)
     Kinzinger
     Kustoff
     LaHood
     LaMalfa
     Lamborn
     Latta
     LaTurner
     Lesko
     Letlow
     Long
     Loudermilk
     Lucas
     Luetkemeyer
     Mace
     Malliotakis
     Mann
     Massie
     McCarthy
     McCaul
     McClain
     McHenry
     McKinley
     Meijer
     Meuser
     Miller (IL)
     Miller (WV)
     Miller-Meeks
     Moolenaar
     Mooney
     Moore (AL)
     Moore (UT)
     Mullin
     Murphy (NC)
     Nehls
     Newhouse
     Norman
     Obernolte
     Owens
     Palazzo
     Palmer
     Pappas
     Pence
     Perry
     Pfluger
     Posey
     Reed
     Reschenthaler
     Rice (SC)
     Rodgers (WA)
     Rogers (AL)
     Rogers (KY)
     Rose
     Rosendale
     Rouzer
     Roy
     Rutherford
     Salazar
     Scalise
     Schweikert
     Scott, Austin
     Sessions
     Simpson
     Smith (MO)
     Smith (NE)
     Smith (NJ)
     Smucker
     Spartz
     Stauber
     Steel
     Stefanik
     Steil
     Steube
     Stewart
     Taylor
     Tenney
     Thompson (PA)
     Tiffany
     Timmons
     Turner
     Upton
     Valadao
     Van Drew
     Van Duyne
     Wagner
     Walberg
     Walorski
     Waltz
     Weber (TX)
     Webster (FL)
     Wenstrup
     Westerman
     Williams (TX)
     Wilson (SC)
     Wittman
     Womack

                             NOT VOTING--5

     Budd
     Bustos
     Cheney
     Johnson (LA)
     Zeldin

                              {time}  1231

  So the bill was passed.
  The result of the vote was announced as above recorded.
  A motion to reconsider was laid on the table.


                          PERSONAL EXPLANATION

  Ms. CHENEY. Madam Speaker, I missed all votes on 4/1 due to illness. 
Had I been present, I would have voted ``nay'' on rollcall No. 103, 
``nay'' on rollcall No. 104, ``nay'' on rollcall No. 105, ``yea'' on 
rollcall No. 106, and ``nay'' on rollcall No. 107.


                          personal explanation

  Mr. BUDD. Madam Speaker, I was unable to attend votes in D.C. due to 
an important constituent event. Had I been present, I would have voted 
``nay'' on rollcall No. 103, ``nay'' on rollcall No. 104, ``nay'' on 
rollcall No. 105, ``yea'' on rollcall No. 106, and ``nay'' on rollcall 
No. 107.

                          ____________________